[Abstract] Identification of protein-protein interactions of bacterial effectors and cellular targets during infection is at the core to understand how bacteria manipulate the infected host to overcome the immune response. Potential interacting proteins might be identified by genetic methods, i.e., two hybrid screens and could be verified by co-immunoprecipitation. 
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Bio-protocol 9 (12) 2. Digest the PCR product and the pCTAP with appropriate restriction enzymes.
3. Ligate the effector protein into pCTAP.
4. Digest the resulting pCTAP effector protein construct with the appropriate enzymes to ligate it in the next step into a plasmid.
Ligate the pCTAP effector protein construct from
Step A4 into a low copy vector. In our case, we used pACYC184 . 2. Grow J774A.1 cells overnight at 37 °C and 5% CO2 in RPMI1640 supplemented with 10% FCS, 100 IU/ml Penicillin and 100 μg/ml Streptomycin and additional 2 mmol Glutamine. 
D. Preparing the protein extracts
All protein purification steps should be performed at 4 °C to prevent the interacting proteins from dissociating. All amounts are indicated for a lysate volume of 10 ml. 
G. Identification of protein complexes
The eluate can be subjected to SDS-PAGE followed by Coomassie staining to determine purification efficiency and allow mass-spectrometry analysis of visible bands.
1. Load the lysate control, the streptavidin sepharose supernatant (Eluate-SBP) and the boiled calmodulin sepharose supernatant (Eluate-CBP) on a 10% SDS-PAGE ( Figure 3 ).
Separate the eluted proteins from
Step F6 (50 μl) by SDS-PAGE. 
